Gastrointestinal Bleeding Treatment Devices Market Outlook 2024: Exclusive Report By The Business Research Company

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2375

The Business Research Company offers in-depth market insights through Gastrointestinal Bleeding Treatment Devices Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The gastrointestinal bleeding treatment devices market size has grown strongly in recent years. It will grow from $0.84 billion in 2023 to $0.9 billion in 2024 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to aging population, lifestyle factors, healthcare infrastructure, gastrointestinal disorders, endoscopy advances.

The gastrointestinal bleeding treatment devices market size is expected to see strong growth in the next few years. It will grow to $1.2 billion in 2028 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to patient-centric care, regulatory changes, telemedicine and remote consultations, increasing gastrointestinal disorders, healthcare investment. Major trends in the forecast period include non-invasive diagnostic technologies, non-invasive diagnostic technologies, precision medicine, remote monitoring and telehealth, artificial intelligence and machine learning.

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=5307&type=smp

Market Segmentation:
The main type of products used in gastrointestinal bleeding treatment devices market are endoscopic mechanical devices, endoscopic thermal devices, and others. Endoscopic mechanical devices are used in the management of GI arterial bleeding. These include hemostatic clips, also known as through-the-scope (TTS) clips, endoscopic detachable snare ligation (EDSL) devices, endoscopic suturing, and over-the-scope clips (OTSC), and will be reviewed for their technology use and clinical application. The gastrointestinal bleeding treatment devices market is also segmented by GI tract division into the lower GI tract and upper GI tract and is used in hospitals or clinics, ambulatory surgical centers, others.

Major Driver - Rise In The Incidences Of Upper Gastrointestinal Bleeding
The rise in the incidences of upper gastrointestinal bleeding is likely to contribute to the growth of the gastrointestinal bleeding treatment devices market during the forecast period. The upper gastrointestinal (GI) bleeding occurs in the esophagus, the stomach, or the upper part of the small intestine and can be caused due to peptic ulcers, esophagitis, enteritis, gastritis, cancer, and other reasons. For instance, according to the National Institute for Health and Care Excellence, in the UK the incidence of acute upper GI bleeding ranges from 84-172 per 100,000 of the population per year. Furthermore, as per the study published in National Library of Medicine - National Institutes of Health in 2023, in-hospital mortality rates for upper GI bleeds stand at approximately 10%. This rate remains consistent up to one month following hospitalization for GI bleed. Over the long term, three years after admission, mortality rates from all causes reach nearly 37%.

Competitive Landscape:
Major companies operating in the gastrointestinal bleeding treatment devices market include CONMED Corporation, Boston Scientific Corporation, US Medical Innovations, Ovesco Endoscopy AG, Olympus Corporation, Cook Medical, Erbe Elektromedizin GmbH, Steris plc., Pfizer Inc., Medtronic, Johnson & Johnson, Abbott Laboratories, Fujifilm Holdings Corporation, Pentax Medical, Merit Medical Systems, Teleflex Incorporated, AngioDynamics, BTG International Ltd., Medline Industries Inc., B. Braun Melsungen AG, Smiths Medical, Terumo Corporation, Nipro Corporation, ConvaTec Group PLC, Coloplast A/S, Hollister Incorporated, Wellspect HealthCare, C. R. Bard Inc., EndoChoice Holdings Inc., GI Supply Inc., Hemostasis LLC

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/gastrointestinal-bleeding-treatment-devices-global-market-report

Top Trend - Increasing Number Of Product Approvals
The increasing number of product approvals is the key trend gaining popularity in the gastrointestinal bleeding treatment devices market. Key players in the market are focusing on product approvals to maintain a comparative advantage over competitors in the industry. For example, in February 2021, EndoClot Plus Inc., a US-based company developing medical devices to meet the needs of the GI professional announced U.S. Food and Drug Administration (FDA) approval for EndoClot Polysaccharide Hemostatic System (EndoClot PHS), which is an advanced product that will assist Gastroenterologists to stop bleeding quickly and effectively. EndoClot PHS is a one-time-use device that consists of a starch-based powder hemostat that is applied directly to the bleeding location using a flexible endoscope.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Gastrointestinal Bleeding Treatment Devices Market Characteristics
3. Gastrointestinal Bleeding Treatment Devices Market Trends And Strategies
4. Gastrointestinal Bleeding Treatment Devices Market - Macro Economic Scenario
5. Gastrointestinal Bleeding Treatment Devices Market Size And Growth
…..
27. Gastrointestinal Bleeding Treatment Devices Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.